Impact of Oral Fast Release Amantadine on Movement Performance in Patients with Parkinson’s Disease

Application of oral fast release amantadine and levodopa may induce an improvement of motor symptoms in patients with Parkinson’s disease (PD). The objective of this trial was to investigate the clinical efficacy of a fast release amantadine sulfate formulation on simple and complex movement perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Muhlack, Siegfried, Müsch, Patricia, Konietzka, Sandra, Woitalla, Dirk, Przuntek, Horst, Müller, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967140/
https://www.ncbi.nlm.nih.gov/pubmed/27721359
http://dx.doi.org/10.3390/pharmaceutics2030313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967140/
https://www.ncbi.nlm.nih.gov/pubmed/27721359
http://dx.doi.org/10.3390/pharmaceutics2030313

Ejemplares similares